-weight heparin haemodialysis for 17 months with several thrombotic episodes of the vascular accesses. At 15.4 years of age he received a second kidney (cadaver donor) and standard triple immunosuppressive therapy. SubcutanIntroduction eous low-molecular-weight heparin ( LMWH) (nadroparin calcium, Fraxiparine, Sanofi Winthrop France, 3075 UI/day) was administered as a prophylactic The most important cause of calcium deposits in measure. humans is hyperparathyroidism (primary or secondEarly graft function was adequate and serum creatinary) with an elevated calcium phosphate product. Systemic deposition in predisposed organs, i.e. cardio-ine declined from a pretransplant value of 830 mmol/l vascular system, lungs, kidney, stomach, and intestines, to 175 mmol/l 10 days after grafting. The patient experiis the most frequent manifestation. Most cases occur enced two episodes of acute rejection; the first occurred in individuals with chronic renal failure while on renal on day 17 and was successfully controlled by methylreplacement therapy who suffer from overt hyperpara-prednisolone pulses and the second occurred on day thyroidism [1,2]. Systemic calcium deposits are also 43 and was treated with orthoclone OKT3 for 10 days. described in other conditions such as calciferol intox-Shortly after discharge, the patient developed another ication, milk-alkali syndrome, rickets, infantile hyper-severe rejection episode due to non-compliance with calcaemia, collagen diseases, leukaemia, lymphoma, the immunosuppressive therapy. He therefore required and multiple myeloma [2 ]. Localized calcium precipita-haemodialysis and concomitant methylprednisolone tion is far less commonly seen and the most frequent pulses. He did not respond to steroid therapy, and presentations are (1 ) 'calcifying vasculitis' with antithymocyte globulin was administred. At this time deposits predominantly seen in the vessels with sub-(day 93), inflammatory subcutaneous nodules were sequent cutaneous necrosis that may lead to gangrene, noted in the abdomen, calves, and arms. A technetium and (2) 'calcifying panniculitis' when calcium deposits 99m bone scan was performed, which showed numerare confined to subcutaneous adipose tissue [2,3]. The ous labelled spots at the same sites where LMWH had latter is the most uncommon form and often results in been injected. There were no signs of systemic involvecutaneous necrosis with secondary infection that may ment ( Figure 1) . ultimately lead to death.
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Pretransplant calcium-phosphate laboratory values The present article reports on calcifying panniculitis were: total serum calcium 2.70 mmol/l, phosphate associated with subcutaneous low-molecular-weight 1.10 mmol/l, and intact parathyroid hormone (PTH ) heparin administration in a boy after renal trans-83 pg/ml (normal 20-55). At the time of the bone scan plantation.
(day 93 ), the results were: total serum calcium 2.70 mmol/l, phosphate 1.90 mmol/l, and PTH 199 pg/ml. He was then receiving oral calcium carbon-
Case report
ate (3 g/day) as a phosphate binder and alfacalcidol (1 mg/day). F.C. developed end-stage renal failure secondary to After the nodules were discovered, oral calcium posterior urethral valves at 13.9 years of age when he carbonate and LMWH were discontinued, which received his first renal transplant (pre-emptive, cadaver resulted in a progressive reduction of the lesions and donor), which was lost 1 month later from arterial finally their complete disappearance. Neither cutaneous necrosis nor secondary infection occurred during the Correspondence and offprint requests to: Pierre Cochat MD, Unité evolution. Graft function progressively improved, and de Néphrologie Pédiatrique, Hô pital Edouard Herriot, 69437 Lyon Cedex 03, France. [8] and humans [4, 5] in association with this disease. The Ca×P product was not elevated on the day of the bone scan, but it was moderately high 2 weeks before ( Table 1 ) .
Subcutaneous LMWH is associated with several cutaneous pathologies, i.e. skin necrosis, subcutaneous haematomas, allergic reactions, and only very rarely Fig. 1 . Technetium 99m bone scan in the child 93 days after receiving with calcified nodules [5, 9, 10] . In the reported patient, the second kidney graft. Note the presence of numerous labelled LMWH should be considered as an important precipitspots at the sites of injection of low-molecular-weight heparin.
ating factor, since neither hyperparathyroidism, nor calcium-phosphate product were excessively elevated. For the above-mentioned reasons, subcutaneous hep-40 ml/min/1.73 m2, PTH 79 pg/ml, total serum calcium 2.30 mmol/l, and serum phosphate 1.20 mmol/l. arins should be regarded as high-risk drugs in patients with hyperparathyroidism, since heparin captures calPhosphate binders were no longer needed and lowdose alfacalcidol ( 0.25 mg/day) was maintained.
cium salts. This might be dangerous, particularly in the presence of even moderate elevations of PTH and Ca×P product.
Discussion
We conclude that calcifying panniculitis is a complication that should be considered in the differential diagnosis when children with any form of chronic renal The exclusive subcutaneous deposition of calcium withfailure develop subcutaneous nodules. This is particuout systemic or arterial involvement supports the dialarly true for patients who receive subcutaneous hepgnosis of calcifying panniculitis in the reported patient.
arin preparations. To our knowledge, isolated calcifying panniculitis has not been described in children so far. In general, tissue of 18 children on dialysis had pulmonary calcifications, and Milliner et al. [7] found tissue calcifications at autopsy in 72 of 120 paediatric patients on dialysis or References following renal transplantation; 60% of these 72 children had systemic (mainly vessel, lung, kidney, and 
